Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation

被引:54
作者
Kolibianakis, E [1 ]
Zikopoulos, K [1 ]
Camus, M [1 ]
Tournaye, H [1 ]
Van Steirteghem, A [1 ]
Devroey, P [1 ]
机构
[1] Free Univ Brussels, Ctr Reprod Med, B-1090 Brussels, Belgium
关键词
GnRH antagonists; modified natural cycle; poor responders;
D O I
10.1093/humrep/deh452
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The purpose of this study was to evaluate the use of the modified natural cycle (MNC) for IVF in poor responders as a last resort prior to oocyte donation. Methods: Thirty-two patients with a regular menstrual cycle, FSH levels on day 3 of the cycle >12 IU/l and one or more failed IVF cycles with five or fewer cumulus-oocyte complexes (COCs) retrieved were included in this prospective study. Recombinant FSH 100 IU and GnRH antagonist 0.25 mg/day were started concomitantly when a follicle with a mean diameter of 14 mm was present at ultrasound. HCG 10 000 IU was administered as soon as the mean follicular diameter was greater than or equal to16 mm. Results: Twenty-five out of 78 cycles performed (32.1%) did not result in oocyte retrieval. In nine out of 53 cycles (16.9%) in which oocyte retrieval was performed, no COCs were retrieved. Following fertilization, embryo transfer was performed in 19 out of 44 cycles in which COCs were retrieved (43.2%). No ongoing pregnancy was achieved in 78 MNCs (0.0%; 95% confidence interval 0.0-4.7). Conclusions: MNC does not offer a realistic chance of parenthood in patients with high levels of FSH on day 3 of the cycle and previous poor response to ovarian stimulation, when offered as a last resort prior to oocyte donation.
引用
收藏
页码:2545 / 2549
页数:5
相关论文
共 15 条
[1]   Outcome of in-vitro fertilization through natural cycles in poor responders [J].
Bassil, S ;
Godin, PA ;
Donnez, J .
HUMAN REPRODUCTION, 1999, 14 (05) :1262-1265
[2]   In-vitro matured metaphase-I oocytes have a lower fertilization rate but similar embryo quality as mature metaphase-II oocytes after intracytoplasmic sperm injection [J].
De Vos, A ;
Van de Velde, H ;
Joris, H ;
Van Steirteghem, A .
HUMAN REPRODUCTION, 1999, 14 (07) :1859-1863
[3]   A review of ten years experience of ICSI [J].
Devroey, P ;
Van Steirteghem, A .
HUMAN REPRODUCTION UPDATE, 2004, 10 (01) :19-28
[4]   In vitro fertilization following natural cycles in poor responders [J].
Feldman, B ;
Seidman, DS ;
Levron, J ;
Bider, D ;
Shulman, A ;
Shine, S ;
Dor, J .
GYNECOLOGICAL ENDOCRINOLOGY, 2001, 15 (05) :328-334
[5]   A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles [J].
Klinkert, ER ;
Broekmans, FJM ;
Looman, CWN ;
Velde, ERT .
FERTILITY AND STERILITY, 2004, 81 (05) :1247-1253
[6]  
Kolibianakis Efstratios M, 2003, Reprod Biomed Online, V7, P190
[7]   Poor responders to ovarian hyperstimulation may benefit from an attempt at natural-cycle oocyte retrieval [J].
Lindheim, SR ;
Vidali, A ;
Ditkoff, E ;
Sauer, MV ;
Zinger, M .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1997, 14 (03) :174-176
[8]   Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran*).: Part II.: Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers [J].
Oberyé, JJL ;
Mannaerts, BMJL ;
Huisman, JAM ;
Timmer, CJ .
FERTILITY AND STERILITY, 1999, 72 (06) :1006-1012
[9]   ADDITION OF A GONADOTROPIN-RELEASING-HORMONE (GNRH) ANTAGONIST AND EXOGENOUS GONADOTROPINS TO UNSTIMULATED IN-VITRO FERTILIZATION (IVF) CYCLES - PHYSIOLOGICAL OBSERVATIONS AND PRELIMINARY EXPERIENCE [J].
PAULSON, RJ ;
SAUER, MV ;
LOBO, RA .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1994, 11 (01) :28-32
[10]   Efficacy of natural cycle IVF: a review of the literature [J].
Pelinck, MJ ;
Hoek, A ;
Simons, AHM ;
Heineman, MJ .
HUMAN REPRODUCTION UPDATE, 2002, 8 (02) :129-139